📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

RAMPART: A phase III multi-arm multi-stage trial of adjuvant checkpoint inhibitors in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of relapse. (2021)

First Author: Oza B

Attributed to: Design of Trials, Meta-analyses and observational studies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.cct.2021.106482

PubMed Identifier: 34538402

Publication URI: http://europepmc.org/abstract/MED/34538402

Type: Journal Article/Review

Volume: 108

Parent Publication: Contemporary clinical trials

ISSN: 1551-7144